Prelude Therapeutics Inc Sustainability Reports
Prelude Therapeutics Incorporated operates as a clinical-stage precision oncology company. The company focuses on discovering and developing small molecule therapies and targeted protein degraders optimized to address key driver mechanisms in cancers with high unmet need.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00K7JY2R5
4 reports from 2021 to 2024
Company Profile
Prelude Therapeutics Incorporated operates as a clinical-stage precision oncology company. The company focuses on discovering and developing small molecule therapies and targeted protein degraders optimized to address key driver mechanisms in cancers with high unmet need.
Reports
4 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
